Market Internals Are Shifting

Global markets are lower this morning as friction between China and the U.S. continues to increase, along with growing concerns over aid to American citizens and businesses.

U.S. vs China Tensions Continue to Rise

Despite a mixed day of trading in Asia, European shares opened higher this morning while U.S. futures also advanced.

Global Markets Dive as Virus Cases Rise

World markets are mostly lower this morning as virus caseloads continue to surge in many countries around the globe. In places like Hong Kong and Australia’s Victoria state, health authorities warn that the number of cases will likely continue to rise if the sick fail to isolate themselves.

Stock Market Rises as Investors Eye Stimulus

Global markets are on the rise this morning after European leaders finally reached a breakthrough agreement over a virus recovery fund.

Wall Street Struggles to Sustain Gains

Much like last Friday, global markets are rather mixed this morning as the number of confirmed virus cases continue to soar to new highs.
stock market recap Stock Market Update

Do FAANG Stocks Have an Open Vacancy?

This year has been one of the wildest rides for Wall Street… The technology sector is leading the market and is up 25%-plus year to date while the S&P 500 is down 3% year to date during the same time period.

Did Global Markets Recover Too Fast?

Global markets are rather mixed this morning as Wall Street slips on uncertainty, especially in light of the recent economic data and the pandemic.

Wall Street’s Hopes Crushed by Shocking Data

Global shares receded this morning as rising numbers of virus cases and deaths remain the constant root of uncertainty. Now, some investors (including myself) are starting to worry that the stock market went too far in its rally. It’s taken less than four months for the S&P 500 to basically return to its record after being down nearly 34%.

First Vaccine Trial Shows Positive Results

Global markets are on the rise this morning as hopes for the development of a virus vaccine intensify once again. The first vaccine tested by Moderna and the U.S. National Institutes of Health uncovered an encouraging immune system boost, paving the way for an even larger study to see if the drug is powerful enough to protect against the virus.